From: Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
Covariate | Univariate model | |||
---|---|---|---|---|
Hazard ratio | 95% confidence interval | P-value | ||
Age | 0.988 | 0.966–1.01 |  | 0.345 |
Male | 1.149 | 0.615–2.147 |  | 0.662 |
Cancer type | ||||
 Papillary | Ref. |  |  |  |
 Follicular | 1.741 | .0489–6.191 |  | 0.391 |
 Poorly differentiated/anaplastic | 5.276 | 2.451–11.354 |  | < 0.0001 |
 Other | 1.134 | 0.432–2.974 |  | 0.797 |
Pleural base lesions on imaging | 0.802 | 0.353–1.819 |  | 0.598 |
Emphysema on imaging | 0.768 | 0.235–2.512 |  | 0.663 |
Prior radiation to the chest | 1.221 | 0.166–8.971 |  | 0.844 |
Cavitation | 0.808 | 0.312–2.089 |  | 0.661 |